QA: Abbott Laboratories in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000001800_2023_Abbott_Laboratories.pdf

Logs

Graph

Absolute values for 0000001800, Abbott Laboratories

  xvar xval
0 AssetsCurrent 25,224,000,000
1 IntangibleAssetsNetIncludingGoodwill 33,253,000,000
2 PropertyPlantAndEquipmentNet 9,162,000,000
3 remainder_Assets 6,799,000,000
4 LiabilitiesCurrent 15,489,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 19,201,999,710
8 SellingGeneralAndAdministrativeExpense 11,225,949,360
9 ResearchAndDevelopmentExpense 2,930,217,144
10 remainder_Expenses 3,920,406,077
11 remainder_Revenues 43,759,884,527
12 remainder_NetIncome 422,782,568
13 remainder_ComprehensiveNetIncome 392,171,009
  yvar yval
0 Assets 74,438,000,000
1 Liabilities 15,489,000,000
2 Expenses 37,278,572,291
3 Revenues 43,759,884,527
4 StockholdersEquity 58,949,000,000
5 NetIncome 6,904,094,804
6 ComprehensiveNetIncome 7,100,180,308
7 BaseVar 85,890,205,198
8 EconomicCapitalRatiobeforeLimitedLiability 3.02
9 EconomicCapitalRatio 3.70

Edgar->Model Mapping

Feature Distribution

Change over Time